Evidence map›Paper›PMID 19951071›Full record

ArticleAntioxidants & redox signaling2010

PAMM: a redox regulatory protein that modulates osteoclast differentiation.

Yan Xu, Leslie R Morse, Raquel Assed Bezerra da Silva, Paul R Odgren, Hajime Sasaki, Philip Stashenko, Ricardo A Battaglino

Abstract read
In one paragraph

Article in Antioxidants & redox signaling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yan XuDepartment of Cytokine Biology, The Forsyth Institute, Boston, Massachusetts, USA.
Leslie R Morse
Raquel Assed Bezerra da Silva
Paul R Odgren
Hajime Sasaki
Philip Stashenko
Ricardo A Battaglino
Harvard University Press · USHarvard University · USUniversity of Massachusetts Chan Medical School · US

Funding

Rehabilitation Medicine Scientist Training (RMST) ProgramK12HD001097 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BONINGER, MICHAEL L. · 1995 to 2016
$14.1M
TOOTH ERUPTION AND BONE RESORPTIONR01DE007444 · NIDCR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ODGREN, PAUL R · 1986 to 2012
$4.8M
NICHD NIH HHS K12 HD001097-08NIDCR NIH HHS R01 DE007444NIDCR NIH HHS R01 DE07444
6 · The paper itself

Abstract

The central role of reactive oxygen species (ROS) in osteoclast differentiation and in bone homeostasis prompted us to characterize the redox regulatory system of osteoclasts. In this report, we describe the expression and functional characterization of PAMM, a CXXC motif-containing peroxiredoxin 2-like protein expressed in bone marrow monocytes on stimulation with M-CSF and RANKL. Expression of wild-type (but not C to G mutants of the CXXC domain) PAMM in HEK293 cells results in an increased GSH/GSSG ratio, indicating a shift toward a more reduced environment. Expression of PAMM in RAW264.7 monocytes protected cells from hydrogen peroxide-induced oxidative stress, indicating that PAMM regulates cellular redox status. RANKL stimulation of RAW 264.7 cells caused a decrease in the GSH/GSSG ratio (reflecting a complementary increase in ROS). In addition, RANKL-induced osteoclast formation requires phosphorylation and translocation of NF-kappaB and c-Jun. In stably transfected RAW 264.7 cells, PAMM overexpression prevented the reduction of GSH/GSSG induced by RANKL. Concurrently, PAMM expression completely abolished RANKL-induced p100 NF-kappaB and c-Jun activation, as well as osteoclast formation. We conclude that PAMM is a redox regulatory protein that modulates osteoclast differentiation in vitro. PAMM expression may affect bone resorption in vivo and help to maintain bone mass.

Indexed as

Cell DifferentiationAmino Acid SequenceAnimalsCells, CulturedCell SurvivalHumansJNK Mitogen-Activated Protein KinasesMiceMolecular Sequence DataNF-kappa BOsteoclastsOxidative StressPeroxiredoxinsRatsRats, Mutant StrainsReverse Transcriptase Polymerase Chain ReactionJNK Mitogen-Activated Protein KinasesNF-kappa BPAMM protein, mousePeroxiredoxinsPRXL2A protein, humanRNA, Messenger

Identifiers

PMID19951071
PMCPMC2877117
OpenAlexW2051385859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.